TB-500 side effects most often reported are injection-site irritation, fatigue, headache, and lightheadedness. Long-term human safety data don't exist yet. TelosRX lays out seven things to know before you decide.
TB-500 has a big reputation in recovery circles. Its safety file is much thinner than the hype suggests.
This list covers the TB-500 side effects people report and what human research actually tested. It also flags risks that come from sourcing, not the peptide itself. Read it before you start, not after.
First, What Is TB-500?
TB-500 is a synthetic peptide modeled on thymosin beta-4 (Tβ4), a protein found in nearly every cell. Tβ4 helps cells move and build their internal scaffolding.
Many TB-500 products are based on a short active region of Tβ4, often listed as the LKKTETQ fragment. Most of the interest comes from animal studies on wound, muscle, and tendon repair.
- Regulatory status: TB-500 is not FDA-approved for any use.
- Evidence base: mostly animal and cell studies.
- Human data: a few early trials, mostly of full-length Tβ4, not TB-500.
For the science behind it, see our TB-500 mechanism of action explainer.
1. Injection-Site Reactions Are the Most Common Complaint
Redness, swelling, itching, or a tender bump where the needle went in top most lists. These usually fade within a day or two.
Technique matters here. Poor skin prep, reusing needles, or hitting the same spot repeatedly makes irritation more likely. Spreading redness, heat, or pus is not a normal reaction and needs prompt medical attention.
2. Fatigue and a "Head Rush" Are Often Reported
Some people describe tiredness, lethargy, or a brief lightheaded feeling shortly after a dose. These reports are mostly anecdotal, not from controlled trials.
That matters for interpretation. Without a placebo group, nobody can say how much comes from TB-500 versus dehydration, a hard workout, or simple nerves about injecting.
3. Headache and Nausea Show Up Occasionally
Mild headaches and an upset stomach appear in user reports and clinic write-ups. Both tend to be short-lived.
A few people also mention puffiness in the hands or feet. If a headache is severe, sudden, or comes with vision changes, consider it urgent and get checked rather than waiting it out.
4. The Best Human Safety Data Aren't Actually on TB-500
This is the point most articles skip. The cleanest human safety study used synthetic full-length thymosin beta-4 given by IV, not a TB-500 injection under the skin.
In that 2010 placebo-controlled study, healthy volunteers received single and then daily doses for 14 days across a wide dose range. Researchers reported it was well tolerated. You can read the thymosin beta-4 volunteer study on PubMed.
Reassuring? Somewhat. But a different molecule, route, and duration means those results can't simply be transferred to TB-500.
5. Long-Term and Cancer Questions Remain Open
Tβ4 supports angiogenesis (new blood-vessel growth) and cell migration. Both help healing. Tumors use the same processes to grow and spread.
No human study has shown TB-500 causes cancer. No study has been long enough to rule it out, either. That's why careful providers screen for active cancer, recent cancer history, and unexplained symptoms first.
Our BPC-157 vs TB-500 comparison covers how the two peptides differ on evidence and risk.
6. Product Quality Can Cause Side Effects of Its Own
Some reactions may come from the vial, not the peptide. Gray-market "research use only" products have no assurance of purity, sterility, or accurate dosing.
FDA has listed the TB-500 fragment among bulk substances that may present significant safety risks in compounding. It flagged possible immunogenicity (an unwanted immune response) from peptide aggregation and impurities. It also noted it had identified no human exposure data.
See the FDA bulk drug substances safety page for the agency's wording. Our guide to reading a peptide COA explains what a legitimate certificate of analysis should show.
Considering TB-500 with a professional involved? Learn how the TelosRX BPC-157 + TB-500 program works. Any prescription is subject to medical approval by a licensed provider who reviews your history asynchronously.
7. A Positive Doping Test Is a Real Risk for Athletes
The World Anti-Doping Agency prohibits thymosin beta-4 and its derivatives, including TB-500, at all times. That applies in and out of competition.
If you compete in a tested sport, a prescription doesn't change that. Check your federation's rules and any therapeutic use exemption process first. Our WADA status guide for peptides explains how testing works.
TB-500 Side Effects at a Glance
| Side effect or risk | How often it's reported | Evidence source | What to do |
|---|---|---|---|
| Injection-site redness or swelling | Most common | User and clinic reports | Rotate sites; report spreading redness |
| Fatigue or lightheadedness | Common | Anecdotal | Sit or lie down; hydrate; log it |
| Headache or nausea | Occasional | Anecdotal | Report if severe or persistent |
| Fluid retention | Occasional | Anecdotal | Mention it to your provider |
| Immune reaction | Unknown | FDA concern, not measured | Seek urgent care for hives or swelling |
| Long-term or cancer risk | Unknown | Theoretical, from mechanism | Disclose cancer history before starting |
Who Should Avoid TB-500?
Because the safety picture is incomplete, the cautious list is long. Providers will typically screen out or pause for:
- Active cancer or a recent cancer diagnosis
- Pregnancy or breastfeeding, where no safety data exist
- Competitive athletes subject to drug testing
- A history of serious allergic reactions to injections
- Unexplained symptoms like weight loss, new lumps, or night sweats
When to Get Medical Help
Most mild reactions settle on their own. Seek care promptly for any of these:
- Hives, facial or throat swelling, or trouble breathing
- Chest pain or a racing, irregular heartbeat
- Fever with a hot, spreading injection-site rash
- Fainting or confusion
Frequently Asked Questions
Is TB-500 safe?
Nobody can say for certain yet. Short-term reports describe mostly mild effects, and an IV study of full-length thymosin beta-4 was well tolerated in healthy volunteers. But TB-500 itself lacks long-term human trials, and FDA has flagged immunogenicity concerns. TB-500 is not FDA-approved, so any use should involve a licensed provider.
How long do TB-500 side effects last?
Commonly reported effects like injection-site redness, fatigue, or lightheadedness usually fade within hours to a couple of days. Effects that persist, worsen, or spread need a medical check. Keep a simple log of dose timing and symptoms. It helps your provider tell a passing reaction from something that needs attention.
Does TB-500 cause cancer?
No study has shown that TB-500 causes cancer in people. The concern is theoretical, because thymosin beta-4 supports blood-vessel growth and cell migration, which tumors also use. Long-term studies designed to detect cancer haven't been done. People with active or recent cancer are usually advised not to use it.
Can TB-500 cause water retention?
Some users report mild puffiness in the hands, feet, or face. These are anecdotal reports rather than findings from controlled trials. Swelling that's sudden, one-sided, painful, or paired with shortness of breath is different and needs urgent medical evaluation. Mention any fluid changes to your provider.
Are TB-500 side effects worse than BPC-157?
There's no head-to-head human data to answer that. Both peptides have mostly preclinical evidence and similar reported reactions, such as injection-site irritation. FDA has raised safety questions about both in compounding. Neither is FDA-approved. A provider can weigh your history and goals when discussing either option.
Will TB-500 show up on a drug test?
Standard workplace drug panels don't usually screen for peptides. Anti-doping labs are different. The World Anti-Doping Agency prohibits thymosin beta-4 and derivatives like TB-500 at all times. Athletes in tested sports should assume it can be detected and check their federation's rules first.
TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service.
Start your private evaluation at TelosRX.